|
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
|
5R42CA153845-03
|
$772,615
|
$772,615
|
SAMPSON, JOHN
|
ANNIAS IMMUNOTHERAPEUTICS, INC.
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
$209,093
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
$371,719
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$1,183
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$1,223
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$32,531
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-16
|
$539,228
|
$539,228
|
DIAMOND, DON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-10S1
|
$300,000
|
$9,000
|
FORMAN, STEPHEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
1R21CA205106-01A1
|
$234,992
|
$234,992
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-04
|
$108,798
|
$54,399
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$2,199
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$3,750
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$73,400
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-03
|
$377,464
|
$377,464
|
CHIOCCA, E.
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-18
|
$421,563
|
$421,563
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Protein B Cell Growth Transformation
|
2R01CA047006-30
|
$532,500
|
$532,500
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
5R01CA170023-05
|
$393,163
|
$393,163
|
Zhao, Bo
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect
|
5UH2CA202723-02
|
$498,956
|
$498,956
|
ERICKSON, DAVID
|
CORNELL UNIVERSITY
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$600
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$115,928
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$1,125
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Viral Oncology Training Grant
|
3T32CA009111-38S1
|
$13,628
|
$4,088
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-39
|
$387,094
|
$116,128
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S1
|
$116,657
|
$1,167
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S2
|
$29,688
|
$297
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA014236-43S3
|
$83,246
|
$832
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA014236-43
|
$5,679,062
|
$56,791
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation
|
5R01CA140337-07
|
$371,732
|
$371,732
|
LUFTIG, MICAH
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$50,488
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$1,200
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$2,042
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Role of B cells in murine gammaherpesvirus 68
|
5R01CA095318-13
|
$368,305
|
$368,305
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Modulation of Host Cell Exosome Content and Function by EBV LMP1
|
5R01CA204621-02
|
$341,410
|
$341,410
|
MECKES, DAVID
|
FLORIDA STATE UNIVERSITY
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-04
|
$688,290
|
$316,613
|
PHIPPS, WARREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mechanism and Function of Mitophagy Regulation by HHV-8 Viral Interferon Regulatory Factor-1
|
1R01CA214131-01A1
|
$351,741
|
$351,741
|
CHOI, YOUNG BONG
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
2P30CA006973-54
|
$7,060,038
|
$141,201
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S1
|
$125,000
|
$2,500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S2
|
$60,000
|
$1,200
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-54S3
|
$25,000
|
$500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-16
|
$384,750
|
$384,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Optimizing Screening for HPV-related Cancers among People Living with HIV
|
5F31CA210660-02
|
$44,044
|
$44,044
|
ROBBINS, HILARY
|
JOHNS HOPKINS UNIVERSITY
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$1,350
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
IRF-1: a brake to limit gammaherpesvirus infection and pathogenesis
|
1R01CA203923-01A1
|
$352,275
|
$352,275
|
TARAKANOVA, VERA
|
MEDICAL COLLEGE OF WISCONSIN
|
|
ATM and gammaherpesvirus infection: a precarious balance
|
5R01CA183593-04
|
$317,475
|
$317,475
|
TARAKANOVA, VERA
|
MEDICAL COLLEGE OF WISCONSIN
|
|
CD206 Targeted Therapy for Kaposi Sarcoma and Tumor Associated Macrophages
|
4R44CA206788-02
|
$939,552
|
$939,552
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Receptor Mediated SPECT Imaging Of Kaposi Sarcoma With 99mTc-Tilmanocept
|
5R44CA192859-03
|
$866,508
|
$866,508
|
COPE, FREDERICK
|
NAVIDEA BIOPHARMACEUTICALS, INC.
|
|
Linxian nutrition intervention trial follow-up study
|
ZIA CP000112-00377
|
$254,770
|
$50,954
|
Abnet, Christian
|
DCEG (NCI)
|
Total relevant funding to Herpes - Other for this search: $50,074,340
|